Autonomic nervous system activity and psychiatric severity in schizophrenia: Regular article

Psychiatry and Clinical Neurosciences

Volumn 63, Issue 4, 2009, Pages 538-545

  Fujibayashi, Mami ^a   Matsumoto, Tamaki ^b   Kishida, Ikuko ^c   Kimura, Tetsuya ^a   Ishii, Chie ^c   Ishii, Norio ^c   Moritani, Toshio ^a  

^a KYOTO UNIVERSITY   (Japan)

^b International Buddhist University   (Japan)

^c Seishinkai Fujisawa Hospital   (Japan)

Author keywords

Autonomic nervous system activity; Global assessment of functioning; Heart rate variability; Power spectral analysis; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLOBAL ASSESSMENT OF FUNCTIONING SCALE; HEART RATE VARIABILITY; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; RATING SCALE; SCHIZOPHRENIA; SPECTROSCOPY;

ANTIPSYCHOTIC AGENTS; AUTONOMIC NERVOUS SYSTEM; AUTONOMIC NERVOUS SYSTEM DISEASES; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PARASYMPATHETIC NERVOUS SYSTEM; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; SYMPATHETIC NERVOUS SYSTEM;

EID: 68149115855     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2009.01983.x     Document Type: Article

References (33)

1. Awad AG, Voruganti LN. The burden of schizophrenia on caregivers: A review. Pharmacoeconomics 2008 26 : 149 162.
2. Goldacre M, Shiwach R, Yeates D. Estimating incidence and prevalence of treated psychiatric disorders from routine statistics: The example of schizophrenia in Oxfordshire. J. Epidemiol. Community Health 1994 48 : 318 322.
3. Ruschena D, Mullen PE, Burgess P et al. Sudden death in psychiatric patients. Br. J. Psychiatry 1998 172 : 331 336.
4. Capasso RM, Lineberry TW, Bostwick JM, Decker PA, St Sauver J. Mortality in schizophrenia and schizoaffective disorder: An Olmsted County, Minnesota cohort: 1950-2005. Schizophr. Res. 2008 98 : 287 294.
5. Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am. Heart J. 2005 150 : 1115 1121.
6. Druss BG, Bradford DW, Rosenheck RA, Radford MJ, Krumholz HM. Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA 2000 283 : 506 511.
7. Conny M, Louis A, Jeroen C, Gerard B, Herman P. Heart rate variability. Ann. Intern. Med. 1993 118 : 436 447.
8. Task Force of the European Society of Cardiology, the North American Society of Pacing and Electrophysiology. Heart rate variability. Standard of measurements, physiological interpretation and clinical use. Circulation 1996 93 : 1043 1065.
9. Moritani T, Hayashi T, Shinohara M, Mimasa F, Masuda I, Nakao K. Sympatho-vagal activities of NIDDM patients during exercise as determined by heart rate spectral analysis. In : Kawamori R, Vranic M, Horton E, Kubota M (eds). Glucose Fluxes, Exercise and Diabetes. Smith-Gordon, London, 1995 91 96.
10. Davy KP, DeSouza CA, Jones PP, Seals DR. Elevated heart rate variability in physically active young and older adult women. Clin. Sci. (Lond.) 1998 94 : 579 584.
11. Matsumoto T, Ushiroyama T, Kimura T, Sakuma K, Moritani T. Therapeutic effects of psychological treatment in the outpatient climacteric clinic evaluated with an index of autonomic nervous system activity. J. Jpn Menopause Soc. 2007 15 : 135 145.
12. Mujica-Parodi LR, Yeragani V, Malaspina D. Nonlinear complexity and spectral analyses of heart rate variability in medicated and unmedicated patients with schizophrenia. Neuropsychobiology 2005 51 : 10 15.
13. American Psychiatric Association. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington, DC, 1994.
14. Sim K, Su A, Fujii S et al. Antipsychotic polypharmacy in patients with schizophrenia: A multicentre comparative study in East Asia. Br. J. Clin. Pharmacol. 2004 58 : 178 183. (Pubitemid 39043998)
15. Hayashi T, Masuda I, Shinohara M, Moritani T, Nakao K. Autonomic nerve activity during physical exercise and postural change: Investigation by power spectral analysis of heart rate variability. Jpn J. Biochem. Exerc. 1994 6 : 30 37.
16. Kimura T, Matsumoto T, Akiyoshi M et al. Body fat and blood lipids in postmenopausal women are related to resting autonomic nervous system activity. Eur. J. Appl. Physiol. 2006 97 : 542 547.
17. Rompelman O, Coenen AJ, Kitney RI. Measurement of heart-rate variability: Part 1: Comparative study of heart-rate variability analysis methods. Med. Biol. Eng. Comput. 1977 15 : 233 239.
18. Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation: A quantitative probe of beat-to-beat cardiovascular control. Science 1981 213 : 220 222.
19. Pagani M, Lombardi F, Guzzetti S et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ. Res. 1986 59 : 178 193.
20. Amano M, Kanda T, Ue H, Moritani T. Exercise training and autonomic nervous system activity in obese individuals. Med. Sci. Sports Exerc. 2001 33 : 1287 1291.
21. Ue H, Masuda I, Yoshitake Y, Inazumi T, Moritani T. Assessment of cardiac autonomic nervous activities by means of ECG R-R interval power spectral analysis and cardiac depolarization-repolarization process. Ann. Noninvas. Electrocardiol. 2000 5 : 336 345.
22. Moritani T, Hayashi T, Shinohara M, Mimasa F, Shibata M. Comparison of sympatho-vagal function among diabetic patients, normal controls and endurance athletes by heart rate spectral analysis. J. Sports Med. Sci. 1993 7 : 31 39.
23. Eckberg DL. Sympathovagal balance: A critical appraisal. Circulation 1997 96 : 3224 3232.
24. Matsumoto T, Miyawaki T, Ue H, Kanda T, Zenji C, Moritani T. Autonomic responsiveness to acute cold exposure in obese and non-obese young women. Int. J. Obes. Relat. Metab. Disord. 1999 23 : 793 800.
25. Bar KJ, Wernich K, Boettger S et al. Relationship between cardiovagal modulation and psychotic state in patients with paranoid schizophrenia. Psychiatry Res. 2008 157 : 255 257.
26. Moritani T, Kimura T, Hamada T, Nagai N. Electrophysiology and kinesiology for health and disease. J. Electromyogr. Kinesiol. 2005 15 : 240 255.
27. Yeragani VK, Pesce V, Jayaraman A, Roose S. Major depression with ischemic heart disease: Effects of paroxetine and nortriptyline on long-term heart rate variability measures. Biol. Psychiatry 2002 52 : 418 429.
28. Ikawa M, Tabuse H, Ueno S, Urano T, Sekiya M, Murakami T. Effects of combination psychotropic drug treatment on heart rate variability in psychiatric patients. Psychiatry Clin. Neurosci. 2001 55 : 341 345.
29. Hempel RJ, Tulen JH, van Beveren NJ, Roder CH, Hengeveld MW. Cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophrenia. J. Psychopharmacol. 2009 (in press).
30. Matsumoto T, Ushiroyama T, Morimura M et al. Autonomic nervous system activity in the late luteal phase of eumenorrheic women with premenstrual symptomatology. J. Psychosom. Obstet. Gynaecol. 2006 27 : 131 139.
31. Jindal R, MacKenzie EM, Baker GB, Yeragani VK. Cardiac risk and schizophrenia. J. Psychiatry Neurosci. 2005 30 : 393 395.
32. Toichi M, Kubota Y, Murai T et al. The influence of psychotic states on the autonomic nervous system in schizophrenia. Int. J. Psychophysiol. 1999 31 : 147 154.
33. Wang YC, Yang CC, Bai YM, Kuo TB. Heart rate variability in schizophrenic patients switched from typical antipsychotic agents to amisulpride and olanzapine: 3-month follow-up. Neuropsychobiology 2008 57 : 200 205.